These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30341887)

  • 1. Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Wang H; Gao X; Zhang X; Gong W; Peng Z; Wang B; Wang L; Chang S; Ma P; Wang S
    Med Sci Monit; 2018 Oct; 24():7482-7492. PubMed ID: 30341887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer.
    Jia W; Sun JY; Jia KY; Liu XC
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis.
    Yang Y; Xian L
    Tumour Biol; 2014 Jul; 35(7):6791-9. PubMed ID: 24729086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Wu G; Jiang B; Liu X; Shen Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
    Kong X; Li Z; Li X
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population.
    Xiao HL; Yang ZT; Han F; Wei HX
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    Miao LF; Ye XH; He XF
    PLoS One; 2020; 15(3):e0216147. PubMed ID: 32155154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
    El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
    Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis in association with GST gene polymorphism and Treatment outcomes of Gemcitabine and Cisplatin/Carboplatin-based chemotherapy among patients with Gallbladder Carcinoma.
    Feroz Z; Kumar R; Tiwari S; Kumar M
    J Cancer Res Ther; 2024 Jan; 20(1):289-296. PubMed ID: 38554336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    Zhang WP; Yang C; Xu LJ; Wang W; Song L; He XF
    Medicine (Baltimore); 2021 Jul; 100(26):e26104. PubMed ID: 34190143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GSTP1 and RRM1 Polymorphisms with the Response and Toxicity of Gemcitabine-cisplatin Combination Chemotherapy in Chinese Patients with Non-small Cell Lung Cancer.
    Yuan ZJ; Zhou WW; Liu W; Wu BP; Zhao J; Wu W; He Y; Yang S; Su J; Luo Y
    Asian Pac J Cancer Prev; 2015; 16(10):4347-51. PubMed ID: 26028097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Among Glutathione S-Transferase T1, M1, and P1 Polymorphisms and the Risk of Oral Leukoplakia.
    He P; Wei M; Wang Y; Liu Q
    Genet Test Mol Biomarkers; 2016 Jun; 20(6):312-21. PubMed ID: 27152506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 May; 121(1):195-202. PubMed ID: 19760040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase polymorphisms (GSTM1, GSTT1 and GSTP1) and their susceptibility to renal cell carcinoma: an evidence-based meta-analysis.
    Yang X; Long S; Deng J; Deng T; Gong Z; Hao P
    PLoS One; 2013; 8(5):e63827. PubMed ID: 23717494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase pi polymorphism contributes to the treatment outcomes of advanced non-small cell lung cancer patients in a Chinese population.
    Chen JB; Wang F; Wu JJ; Cai M
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.
    Ye H; Shao M; Shi X; Wu L; Xu B; Qu Q; Qu J
    Sci Rep; 2017 Jun; 7(1):2670. PubMed ID: 28572675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies.
    Gong M; Dong W; Shi Z; Xu Y; Ni W; An R
    PLoS One; 2012; 7(11):e50587. PubMed ID: 23189206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population.
    Sharma N; Singh A; Singh N; Behera D; Sharma S
    Cancer Epidemiol; 2015 Dec; 39(6):947-55. PubMed ID: 26529288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
    Risch A; Wikman H; Thiel S; Schmezer P; Edler L; Drings P; Dienemann H; Kayser K; Schulz V; Spiegelhalder B; Bartsch H
    Pharmacogenetics; 2001 Dec; 11(9):757-64. PubMed ID: 11740339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.